Showing results (491-500 of 2,506) with videos related to
Sort By:
Pageof 251
Endocrine-Related Cancer|January 25, 2017
Hypo-methylation mediates chromosomal instability in pancreatic NETI Marinoni, A Wiederkeher, T Wiedmer, et al.Endocrine-Related Cancer|April 22, 2017
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinomaTheo S Plantinga, Mirela S Petrulea, Marije Oosting, et al.Endocrine-Related Cancer|October 5, 2016
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and futureKjell Öberg, Steven W J LambertsEndocrine-Related Cancer|January 31, 2014
Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapiesJosé O Alemán, Azeez Farooki, Monica GirotraEndocrine-Related Cancer|February 7, 2014
Current views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaAles Vicha, David Taieb, Karel PacakEndocrine-Related Cancer|July 12, 2019
ErbB-2 signaling in advanced prostate cancer progression and potential therapyDannah R Miller, Matthew A Ingersoll, Ming-Fong LinEndocrine-Related Cancer|May 3, 2015
Procalcitonin for detecting medullary thyroid carcinoma: a systematic reviewPierpaolo Trimboli, Ettore Seregni, Giorgio Treglia, et al.Endocrine-Related Cancer|October 25, 2019
Soluble CD105 is prognostic of disease recurrence in prostate cancer patientsVeronica R Placencio-Hickok, Anisha Madhav, Sungjin Kim, et al.Endocrine-Related Cancer|October 24, 2019
Pituitary tumour fibroblast-derived cytokines influence tumour aggressivenessPedro Marques, Sayka Barry, Eivind Carlsen, et al.Endocrine-Related Cancer|August 17, 2016
Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriersRoger L Milne, Antonis C AntoniouPageof 251